Abstract:We thank Cao et al. [1] for their insightful comments on our manuscript recently published in the European Journal of CardioThoracic Surgery [2]. Cao et al. addressed, in their letter to the editor, two important and controversial aspects of segmentectomy comparing with lobectomy for early stage non-small-cell lung cancer (NSCLC), which we would like to discuss in detail. The first issue emphasized by Cao et al. was the rationality of using combined overall survival (OS) and cancer-specific survival (CSS) outcomes to compare the two different surgical procedures. Our study aimed at assessing the survival difference between segmentectomy and lobectomy. We must admit that combining OS and CSS does have some shortcomings such as it may overestimate the adverse survival outcomes of segmentectomy procedures just as Cao et al. pointed out. However, the data we based our study on were divergent, with few providing CSS, whereas most of the published studies use OS to assess the two procedures. The overestimation exists in each published study which selected the patients with limited cardiopulmonary function as candidates for segmentectomy; it is inevitable for us to avoid such overestimation. Besides, a previously published paper also used combined OS and CSS to assess oncological outcomes [3]. It is insufficient to conduct meta-analysis for the comparison of segmentectomy and lobectomy exclusively based on either OS or CSS data and it would be possible in future to conduct such a meta-analysis with subgroups of OS and CSS as new suitable data are published. The other issue proposed by Cao et al. is to differentiate the intentional segmentectomy from the compromised one; recently, several studies also excluded compromised segmentectomy and aimed to compare intentional segmentectomy with lobectomy [4, 5]. Some studies, such as Tsutani et al. [6], reported the use of propensity score analysis. We agree with Cao et al. that these studies would be the future direction. However, as the data are insufficient, it is still meaningful to estimate the oncological effects of segmentectomy including both compromised and intentional procedures. We are also undertaking a prospective study aimed at selecting the optimal candidates for intentional segmentectomy. The issue that segmentectomy, especially the intentional one, or lobectomy, which is suitable for early stage NSCLC, would be long-existing until the future randomized controlled trials such as CALGB 140503 and JCOG 0802. We are grateful to Cao et al. [1] for their kind and insightful comments, and we thank them for taking the time to remark on our work.

Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis.

Meta-analysis of Lobectomy, Segmentectomy, and Wedge Resection for Stage I Non-Small Cell Lung Cancer.

Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review

Comparative Analysis of the Long-Term Outcomes of Segmentectomy and Lobectomy for Stage IA1 Lung Adenocarcinoma in Patients with or Without Previous Malignancy of Other Organs: a Population-Based Study

Reply to Cao Et Al.

Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis.

Sublobectomy Versus Lobectomy for Stage I Non-Small-Cell Lung Cancer, A Meta-Analysis of Published Studies

Survival Following Segmentectomy or Lobectomy in Elderly Patients with Early-Stage Lung Cancer

Segmentectomy and Wedge Resection for Elderly Patients with Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Survival outcomes of segmentectomy and lobectomy for early stage non-small cell lung cancer: a systematic review and meta-analysis

Sublobectomy Versus Lobectomy for Long-Term Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer with a Tumor Size ≤2 Cm Accompanied by Visceral Pleural Invasion: a SEER Population-Based Study

Sublobar Resection Is Associated With Better Perioperative Outcomes In Elderly Patients With Clinical Stage I Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

Comparative analysis of the clinical effects of different thoracoscopic resection in the treatment of Stage I Non-Small Cell Lung Cancer

Time Trend of Mediastinal Lymph Node Dissection in Stage IA Non-Small Cell Lung Cancer Patient Who Undergo Lobectomy: a Retrospective Study of Surveillance, Epidemiology, and End Results (SEER) Database

Segmentectomy versus Lobectomy in the United States

Comparison of Outcomes Following Segmentectomy or Lobectomy for Patients with Clinical N0 Invasive Lung Adenocarcinoma of 2 Cm or Less in Diameter

Survival and Long-Term Cause-Specific Mortality Associated with Stage IA Lung Adenocarcinoma after Wedge Resection Vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis

Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21-30 mm

Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis

Comparative Study of the Anatomic Segmentectomy Versus Lobectomy for Clinical Stage I-A Peripheral Lung Cancer by Video Assistant Thoracoscopic Surgery